Results 31 to 40 of about 5,690,964 (274)

Deep Learning Approach for Early Stage Lung Cancer Detection [PDF]

open access: yesarXiv, 2023
Lung cancer is the leading cause of death among different types of cancers. Every year, the lives lost due to lung cancer exceed those lost to pancreatic, breast, and prostate cancer combined. The survival rate for lung cancer patients is very low compared to other cancer patients due to late diagnostics.
arxiv  

Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.

open access: yesJournal of the American Medical Association (JAMA), 2002
CONTEXT Associations have been found between day-to-day particulate air pollution and increased risk of various adverse health outcomes, including cardiopulmonary mortality.
A. Pope   +6 more
semanticscholar   +1 more source

Non‐small cell lung cancer in China

open access: yesCancer Communications, 2022
In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors for lung cancer include tobacco use, family history, radiation exposure, and the presence of chronic lung diseases. Most early‐stage non‐small cell lung cancer
Peixin Chen   +3 more
semanticscholar   +1 more source

Double Integral Enhanced Zeroing Neural Network Optimized with ALSOA fostered Lung Cancer Classification using CT Images [PDF]

open access: yesarXiv, 2023
Lung cancer is one of the deadliest diseases and the leading cause of illness and death. Since lung cancer cannot predicted at premature stage, it able to only be discovered more broadly once it has spread to other lung parts. The risk grows when radiologists and other specialists determine whether lung cancer is current.
arxiv  

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

open access: yesMolecular Cancer, 2022
Primary lung cancer is one of the most common malignant tumors in China. Approximately 60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is necessary to find new tumor markers for early diagnosis and individualized ...
Wen Li   +18 more
semanticscholar   +1 more source

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Lung cancer is the second most common cancer and the leading cause of cancer death in the US. In 2020, an estimated 228 820 persons were diagnosed with lung cancer, and 135 720 persons died of the disease.
A. Krist   +18 more
semanticscholar   +1 more source

First‐Line Atezolizumab plus Chemotherapy in Extensive‐Stage Small‐Cell Lung Cancer

open access: yesNew England Journal of Medicine, 2018
BACKGROUND Enhancing tumor‐specific T‐cell immunity by inhibiting programmed death ligand 1 (PD‐L1)–programmed death 1 (PD‐1) signaling has shown promise in the treatment of extensive‐stage small‐cell lung cancer.
L. Horn   +20 more
semanticscholar   +1 more source

Effect of Upper Arm Position Changes on the Occurrence of Ipsilateral Shoulder Pain After Single-Operator Port Thoracoscopy

open access: yesFrontiers in Surgery, 2022
BackgroundThe aim of this study was to explore the factors associated with the occurrence of ISP after VATS to reduce the incidence of ISP and improve patients' quality of life.MethodsThe data of patients were collected between June 2020 and August 2020 ...
Dian Ren   +14 more
doaj   +1 more source

Classification of Histopathology Images of Lung Cancer Using Convolutional Neural Network (CNN) [PDF]

open access: yesarXiv, 2021
Cancer is the uncontrollable cell division of abnormal cells inside the human body, which can spread to other body organs. It is one of the non-communicable diseases (NCDs) and NCDs accounts for 71% of total deaths worldwide whereas lung cancer is the second most diagnosed cancer after female breast cancer.
arxiv  

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

open access: yesNew England Journal of Medicine, 2018
BACKGROUND Nivolumab plus ipilimumab showed promising efficacy for the treatment of non–small‐cell lung cancer (NSCLC) in a phase 1 trial, and tumor mutational burden has emerged as a potential biomarker of benefit.
M. Hellmann   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy